What Is hMG?
hMG (human menopausal gonadotropin), also called menotropin, is a gonadotropin preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Published studies describe FSH and LH as the principal gonadotropins present in hMG preparations.
Studies have also identified human chorionic gonadotropin (hCG) in some hMG preparations. The composition of hMG can therefore include FSH, LH, hCG, and other proteins, depending on the preparation analyzed.
Research Overview Table
Chemical and Molecular Characteristics
Certificates:
Mechanism of Action Under Investigation
hMG contains FSH and LH/hCG activity that acts through FSH receptors (FSHR) and LH/choriogonadotropin receptors (LHCGR). Both are G protein-coupled receptors. Published in-vitro research with hMG preparations has investigated FSHR–LHCGR receptor complex formation and activation of intracellular cAMP and Ca²⁺ signaling.
The same hMG study investigated β-arrestin 2 recruitment as another receptor-signaling response. Differences between hMG preparations produced differences in cAMP and β-arrestin signaling, which the researchers associated with differences in their gonadotropin composition. The relative contribution of individual components to these signaling patterns remains uncertain.
Scientific Research Context
hMG has a long-established research record, including biochemical characterization, in vitro studies, animal research, randomized clinical trials, and meta-analyses. Early research focused on defining the properties and composition of hMG preparations. Later studies compared different hMG preparations and evaluated them in controlled clinical settings. The evidence base has therefore progressed from basic characterization to comparative and clinical research, with a substantial published literature spanning several decades.
hMG Biology and Biological Pathways
Primary Biological Function
hMG is a gonadotropin preparation containing FSH and LH activity. FSH and LH regulate reproductive physiology and have distinct but complementary biological functions. Published research identifies their roles in regulating follicular development, steroidogenesis, and gonadal function. Researchers investigate these functions to characterize the biological activity of the gonadotropin components present in hMG preparations.
Relevant Metabolic or Signalling Pathways
Research on hMG-associated gonadotropin signaling has focused mainly on the cAMP/PKA pathway and related intracellular signaling in gonadal cells. Published research also describes Ca²⁺ signaling and, in some experimental systems, ERK/MAPK signaling. Researchers investigate these pathways to understand how FSH and LH signaling is integrated with cellular functions such as steroidogenesis and gonadal cell regulation.
Tissue-Specific Biology
The biological effects of FSH and LH differ according to the target tissue and cell type. In the ovary, FSH and LH participate in follicular development and steroidogenic activity. In the testis, LH is associated with Leydig-cell steroidogenesis, while FSH regulates Sertoli-cell function. This tissue-specific biology is important when interpreting research involving hMG preparations.
Experimental Biomarkers
Published hMG studies have measured FSH, LH, estradiol, progesterone, and androgen levels in serum and follicular fluid. Researchers have also measured FSHR and LHCGR expression and related cellular signaling markers in experimental systems. These biomarkers characterize gonadotropin-associated biological responses and compare the biological profiles of different hMG preparations.
Laboratory Investigation Methods
Published hMG research has used HPLC, immunoassays, electrophoresis, mass spectrometry, and biological assays to characterize its composition and biological activity. Cell-based studies have also used transfected cells and human granulosa cells to examine gonadotropin-related responses. These methods allow researchers to assess the molecular composition, biochemical properties, and biological activity of hMG preparations.
Experimental Models Used in Published Research
Published hMG research has used cell-based, tissue, rodent, and nonhuman primate models. Each model has limitations related to experimental conditions, species differences, and how closely the model represents human reproductive biology.
Cell-Based Models
Studies have used transfected HEK293 cells and human granulosa-lutein cells. These models are limited because cultured or engineered cells do not reproduce the full cellular and physiological environment of intact reproductive tissues.
Tissue and Follicle Models
Published research has used human and rat testicular organ cultures and mouse ovarian follicle cultures. These models retain tissue structure but remain limited by culture conditions and cannot fully represent whole-organ or systemic physiology.
Rodent Models
Researchers have used mouse and rat models in hMG research. Their main limitation is differences between rodent and human reproductive biology, which can limit direct translation of findings to humans.
Nonhuman Primate Models
Research has used cynomolgus monkeys and chimpanzees as nonhuman primate models. These models more closely represent aspects of human reproductive biology than rodents, but species differences and limited sample sizes remain important limitations.
Published Scientific Research
Molecular and Biochemical Composition
Published research has investigated the composition of hMG preparations, including FSH, LH, hCG, protein impurities and different FSH and LH isoforms. Studies have also examined variation between hMG lots and preparations, including differences in their biochemical and biological characteristics.
hCG Content in hMG Preparations
Studies have specifically investigated the presence and amount of hCG in commercial hMG preparations. Research has compared hCG content between different products and production batches and examined the contribution of hCG to the LH-related activity present in hMG.
Cellular Signaling of hMG Preparations
In vitro research has investigated whether different hMG preparations produce different cellular signaling responses. Published research has examined FSHR–LHCGR heteromer formation, intracellular calcium and cAMP signaling, β-arrestin 2 recruitment, and steroid production following exposure to different preparations.
Ovarian and Follicular Research
Clinical research has investigated the effects of hMG during controlled ovarian stimulation, including follicular development, circulating gonadotropin concentrations and ovarian steroid profiles. Studies have also compared hMG with purified FSH and other gonadotropin preparations in IVF-related research.
Clinical Comparison of hMG Preparations
Randomized clinical studies have investigated differences between hMG preparations and between hMG and recombinant FSH in controlled ovarian stimulation and IVF. More recent research has also compared different highly purified hMG preparations in women undergoing IVF.
Limitations of Current Research
Evidence Is Predominantly Preclinical
The evidence base for hMG is not predominantly preclinical. This limits the usefulness of applying this category as a general limitation to hMG research. Human clinical evidence represents a substantial part of the published literature.
Human Clinical Evidence
Human clinical evidence for hMG is substantial, but the published studies differ in patient populations, stimulation protocols, hMG preparations, comparators, and study designs. Systematic reviews have included randomized trials using different ovarian stimulation protocols, while individual trials have studied specific patient groups and treatment settings. These differences limit direct comparison across the full clinical literature.
Species Differences
Preclinical reproductive studies cannot be assumed to directly reflect the biology of human hMG. Species differences in reproductive physiology, gonadotropin regulation, and ovarian function may influence the translation of experimental observations to humans. This restricts the interpretation of the animal findings independent of the human clinical literature.
Study Design Limitations
Published clinical studies have used different gonadotropin doses, stimulation protocols, comparators, and outcome measures. Some studies are relatively small, while others use larger randomized designs. Such methodological differences can introduce heterogeneity across the evidence base and make results from individual studies difficult to compare directly.
Independent Replication
Some findings have been investigated in multiple clinical studies and reviews, but replication is not uniform across every hMG preparation or research question. Differences in product composition and study protocols also complicate direct replication. Additional independent studies using clearly defined preparations and standardized methods would strengthen comparisons between findings.
Long-Term Evidence
Long-term hMG studies are available, including follow-up research involving repeated treatment cycles and prolonged gonadotropin exposure. However, follow-up duration and study populations vary across the literature. This variation limits consistent assessment of outcomes over extended periods and makes long-term evidence less uniform than evidence from individual treatment cycles.
Analytical Documentation
HPLC separates the components of a sample and can be used to examine chromatographic purity. Validated HPLC procedures may also provide information about identity and the amount of a particular component.
LC-MS adds mass spectrometric measurement to chromatographic separation. The resulting mass information can help characterize and identify compounds. NMR takes a different approach by examining the chemical environment of nuclei within a molecule. It can therefore provide structural information when the sample is suitable for NMR analysis.
A Certificate of Analysis brings together the analytical results recorded for a specific batch. Depending on the material and testing requirements, this may include identity, purity, composition and other quality specifications. Such documentation helps establish the quality and identity of the material used in laboratory research. It does not demonstrate biological performance.
Storage and Laboratory Handling
The hMG vial should remain refrigerated at 2–8°C, as stated on the Certificate of Analysis. Qualified laboratory personnel should handle and store the material under appropriate laboratory conditions.
Good laboratory practice includes clean handling and measures that limit contamination of the vial or its contents. Personnel should maintain the specified storage conditions during laboratory handling. The material is intended for laboratory research use only.
Why Researchers Choose Direct SARMs?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.
Frequently asked questions
Why choose us?
Direct SARMs is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.
Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.
Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs, we aim to make the research supply process simple, clear, and reliable.